Kinsale Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.5M Buy
84,464
+7,462
+10% +$1.74M 2.84% 3
2026
Q1
$18.8M Buy
77,002
+3,239
+4% +$754K 3.02% 4
2025
Q4
$15.3M Buy
73,763
+2,919
+4% +$577K 2.53% 5
2025
Q3
$13.1M Buy
70,844
+5,713
+9% +$979K 2.4% 11
2025
Q2
$9.95M Buy
65,131
+6,800
+12% +$1.05M 2.04% 17
2025
Q1
$9.67M Buy
58,331
+7,662
+15% +$1.2M 2.38% 11
2024
Q4
$7.33M Buy
50,669
+6,418
+15% +$995K 1.97% 17
2024
Q3
$7.17M Buy
44,251
+6,381
+17% +$1.02M 2.11% 15
2024
Q2
$5.54M Buy
37,870
+7,946
+27% +$1.18M 1.92% 17
2024
Q1
$4.73M Buy
29,924
+5,180
+21% +$825K 1.87% 13
2023
Q4
$3.88M Buy
24,744
+6,587
+36% +$1.01M 1.92% 10
2023
Q3
$2.83M Buy
18,157
+4,993
+38% +$824K 1.61% 8
2023
Q2
$2.18M Buy
13,164
+4,933
+60% +$796K 1.32% 8
2023
Q1
$1.28M Buy
8,231
+3,706
+82% +$598K 0.93% 6
2022
Q4
$799K Buy
+4,525
New +$781K 0.7% 5

Other funds holding JNJ

Kinsale Capital Group's JNJ Position: Q2 2026 in Review

Kinsale Capital Group increased its Johnson & Johnson (JNJ) stake by 9.7% in Q2 2026, buying an estimated $1.74M and bringing the position to 84,464 shares worth $21.5M. The position accounts for 2.84% of the portfolio, ranked #3.

Kinsale Capital Group first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,652 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Kinsale Capital Group held 84,464 shares of Johnson & Johnson worth $21.5M as of Q2 2026.
  • Kinsale Capital Group bought 7,462 Johnson & Johnson shares in Q2 2026, an estimated $1.74M.
  • Johnson & Johnson made up 2.84% of Kinsale Capital Group's portfolio in Q2 2026, its #3 holding.
  • Kinsale Capital Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,652 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kinsale Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.